Ciphergen s Q4 Revenues Increase While Losses Widen | GenomeWeb

NEW YORK, Feb 15 – Buoyed by strong sales of its ProteinChip systems, Ciphergen reported $3 million in fourth quarter earnings, up from $2 million in 1999, while losses widened to  $4.9 million, from $1.9 million for the year-ago quarter.

 

Ciphergen’s total revenues for 2000 increased 78 percent, to $8.9 million, from $5 million in 1999.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.